
Sessions throughout the conference will emphasize the role of the manufacturer in ensuring the integrity of the 340B program and will focus on:
• Updates regarding HRSA audits and other integrity initiatives
• Pricing and contracting strategies with the prime vendor
• Medicaid and duplicate discounts
• Orphan Drug Exclusion
• GPO Prohibition
• Contract Pharmacies
On Friday, March 28th, join Chris, along with other 340B experts in the sessions:
• Update on the 340B Program
• Latest Developments for the 340B Orphan Drug Rule
Plus! He will also be available in a parking lot Q&A session on Friday at the end of the track — 340B Summit for Manufacturers, in collaboration with Apexus' 340B University.
To learn more, download our agenda.
Register with code XP1951BLOG and receive 15% off of the standard rate: http://bit.ly/1dncAkp. If you have any questions about the event, feel free to contact Kate Devery (Kdevery@iirusa.com) For more information visit our homepage.
We hope to see this March!
Cheers,
The GP Team
Opt-in for GP updates
GP Twitter
GP LinkedIn
No comments:
Post a Comment